Mutant epidermal growth factor receptor up-regulates molecular effectors of tumor invasion

Cancer Research

Volumn 62, Issue 12, 2002, Pages 3335-3339

  Lal, Anita ^a   Glazer, Chad A ^a   Martinson, Holly M ^a   Friedman, Henry S ^a   Archer, Gary E ^a   Sampson, John H ^a   Riggins, Gregory J ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; GENE PRODUCT; METALLOPROTEINASE; SERINE PROTEINASE; TYRPHOSTIN;

ARTICLE; CANCER INVASION; CARCINOGENESIS; CONTROLLED STUDY; CORRELATION ANALYSIS; GENE MUTATION; GLIOBLASTOMA; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN FUNCTION; RECEPTOR UPREGULATION; TRANSCRIPTION REGULATION; TUMOR CELL; TUMOR GROWTH;

ANIMALS; ENZYME INHIBITORS; EXTRACELLULAR MATRIX PROTEINS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; HUMANS; METALLOENDOPEPTIDASES; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; RECEPTOR, EPIDERMAL GROWTH FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SERINE ENDOPEPTIDASES; TRANSFECTION; TUMOR CELLS, CULTURED; TYRPHOSTINS; UP-REGULATION;

EID: 0037096945     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification
2. Identical splicing of aberrant epidermal growth factor receptor transcripts from amplified rearranged genes in human glioblastomas
3. The enhanced tumorigenic activity of a mutant epidermal growth factor receptor common in human cancers is mediated by threshold levels of constitutive tyrosine phosphorylation and unattenuated signaling
4. Cell surface localization and density of the tumor-associated variant of the epidermal growth factor receptor EGFRvlII
5. A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity
6. Aberrant receptor signaling in human malignant gliomas: Mechanisms and therapeutic implications
7. Distribution of epidermal growth factor receptor gene amplification in brain tumors and correlation to prognosis
8. Expression of activated epidermal growth factor receptors. Ras- guanosine triphosphate, and mitogen-activated protein kinase in human glioblastoma multiforme specimens
9. A public database for gene expression in human cancers
10. Transcriptional response to hypoxia in human tumors
11. Characterization of the epidermal growth factor receptor in human glioma cell lines and xenografts
12. Tyrosine kinase inhibition: An approach to drug development
13. Tyrphostin AG 1478 preferentially inhibits human glioma cells expressing truncated rather than wild-type epidermal growth factor receptors
14. Rowinsky pharmacologic study of OSI-774, an epidermal growth factor receptor tyrosine kinase inhibitor, in patients with advanced solid malignancies
15. OSI-774 OSI Pharmaceuticals
16. Epidermal growth factor receptor signaling and the invasive phenotype of ovarian carcinoma cells
17. Epidermal growth factor receptor mutation type III transfected into a small cell lung cancer cell line is predominantly localized at the cell surface and enhances the malignant phenotype
18. Expression of collagenase-3 (MMP-13) enhances invasion of human fibrosarcoma HT-1080 cells
19. Cumulative influence of matrix metalloproteinase-1 and -2 in the migration of melanoma cells within three-dimensional type I collagen lattices
20. Invasive properties of serous human epithelial ovarian tumors are related to Ets-1. MMP-1 and MMP-9 expression
21. A potential marker protease of invasiveness, seprase, is localized on invadopodia of human malignant melanoma cells
22. Seprase, a membrane-bound protease, is overexpressed by invasive ductal carcinoma cells of human breast cancers
23. Receptor for interleukin 13 is a marker and therapeutic target for human high-grade gliomas